Jaideep Dhariwal1,2, Aoife Cameron1,2, Maria-Belen Trujillo-Torralbo1,2, Ajerico Del Rosario1,2, Eteri Bakhsoliani1,2, Malte Paulsen3, David J Jackson1,2,4, Michael R Edwards1,2, Batika M J Rana5, David J Cousins2,5,6, Trevor T Hansel1,2, Sebastian L Johnston1,2, Ross P Walton1,2. 1. 1 Airway Disease Infection Section, National Heart and Lung Institute, London, United Kingdom. 2. 2 Medical Research Council Asthma UK Centre in Allergic Mechanisms of Asthma, London, United Kingdom. 3. 3 St. Mary's Flow Cytometry Core Facility, London, United Kingdom. 4. 4 Guy's and St. Thomas' National Health Service Trust, London, United Kingdom. 5. 5 Department of Respiratory Medicine & Allergy, King's College London, London, United Kingdom; and. 6. 6 National Institute for Health Research Respiratory Biomedical Research Unit, Department of Infection, Immunity & Inflammation, Leicester Institute for Lung Health, University of Leicester, Leicester, United Kingdom.
Abstract
RATIONALE: Newly characterized type 2 innate lymphoid cells (ILC2s) display potent type 2 effector functionality; however, their contribution to allergic airways inflammation and asthma is poorly understood. Mucosal biopsy used to characterize the airway mucosa is invasive, poorly tolerated, and does not allow for sequential sampling. OBJECTIVES: To assess the role of ILC2s during nasal allergen challenge in subjects with allergic rhinitis using novel noninvasive methodology. METHODS: We used a human experimental allergen challenge model, with flow cytometric analysis of nasal curettage samples, to assess the recruitment of ILC2s and granulocytes to the upper airways of subjects with atopy and healthy subjects after allergen provocation. Soluble mediators in the nasal lining fluid were measured using nasosorption. MEASUREMENTS AND MAIN RESULTS: After an allergen challenge, subjects with atopy displayed rapid induction of upper airway symptoms, an enrichment of ILC2s, eosinophils, and neutrophils, along with increased production of IL-5, prostaglandin D2, and eosinophil and T-helper type 2 cell chemokines compared with healthy subjects. The most pronounced ILC2 recruitment was observed in subjects with elevated serum IgE and airway eosinophilia. CONCLUSIONS: The rapid recruitment of ILC2s to the upper airways of allergic patients with rhinitis, and their association with key type 2 mediators, highlights their likely important role in the early allergic response to aeroallergens in the airways. The novel methodology described herein enables the analysis of rare cell populations from noninvasive serial tissue sampling.
RATIONALE: Newly characterized type 2 innate lymphoid cells (ILC2s) display potent type 2 effector functionality; however, their contribution to allergic airways inflammation and asthma is poorly understood. Mucosal biopsy used to characterize the airway mucosa is invasive, poorly tolerated, and does not allow for sequential sampling. OBJECTIVES: To assess the role of ILC2s during nasal allergen challenge in subjects with allergic rhinitis using novel noninvasive methodology. METHODS: We used a human experimental allergen challenge model, with flow cytometric analysis of nasal curettage samples, to assess the recruitment of ILC2s and granulocytes to the upper airways of subjects with atopy and healthy subjects after allergen provocation. Soluble mediators in the nasal lining fluid were measured using nasosorption. MEASUREMENTS AND MAIN RESULTS: After an allergen challenge, subjects with atopy displayed rapid induction of upper airway symptoms, an enrichment of ILC2s, eosinophils, and neutrophils, along with increased production of IL-5, prostaglandin D2, and eosinophil and T-helper type 2 cell chemokines compared with healthy subjects. The most pronounced ILC2 recruitment was observed in subjects with elevated serum IgE and airway eosinophilia. CONCLUSIONS: The rapid recruitment of ILC2s to the upper airways of allergic patients with rhinitis, and their association with key type 2 mediators, highlights their likely important role in the early allergic response to aeroallergens in the airways. The novel methodology described herein enables the analysis of rare cell populations from noninvasive serial tissue sampling.
Authors: Joanne L Shaw; Samer Fakhri; Martin J Citardi; Paul C Porter; David B Corry; Farrah Kheradmand; Yong-Jun Liu; Amber Luong Journal: Am J Respir Crit Care Med Date: 2013-08-15 Impact factor: 21.405
Authors: Hannah H Walford; Sean J Lund; Rachel E Baum; Andrew A White; Christopher M Bergeron; Jacob Husseman; Kelly J Bethel; David R Scott; Naseem Khorram; Marina Miller; David H Broide; Taylor A Doherty Journal: Clin Immunol Date: 2014-09-16 Impact factor: 3.969
Authors: Ian P Hall; Andrew V Fowler; Abhya Gupta; Kay Tetzlaff; Michael C Nivens; Maria Sarno; Helen A Finnigan; Eric D Bateman; E Rand Sutherland Journal: Pulm Pharmacol Ther Date: 2015-04-08 Impact factor: 3.410
Authors: Dave Singh; Paul Cadden; Michael Hunter; Lisa Pearce Collins; Mike Perkins; Roy Pettipher; Elizabeth Townsend; Shân Vinall; Brian O'Connor Journal: Eur Respir J Date: 2012-04-10 Impact factor: 16.671
Authors: Christina A Christianson; Nicholas P Goplen; Iram Zafar; Chaoyu Irvin; James T Good; Donald R Rollins; Balachandra Gorentla; Weimin Liu; Magdalena M Gorska; HongWei Chu; Richard J Martin; Rafeul Alam Journal: J Allergy Clin Immunol Date: 2015-01-21 Impact factor: 10.793
Authors: Aimee Hoskins; Sara Reiss; Pingsheng Wu; Ning Chen; Wei Han; Rui-hong Do; Rasul Abdolrasulnia; Ryszard Dworski Journal: Am J Respir Crit Care Med Date: 2012-11-29 Impact factor: 21.405
Authors: Ceri A Fielding; Rachel M McLoughlin; Louise McLeod; Chantal S Colmont; Meri Najdovska; Dianne Grail; Matthias Ernst; Simon A Jones; Nicholas Topley; Brendan J Jenkins Journal: J Immunol Date: 2008-08-01 Impact factor: 5.422
Authors: Maryam Salimi; Jillian L Barlow; Sean P Saunders; Luzheng Xue; Danuta Gutowska-Owsiak; Xinwen Wang; Li-Chieh Huang; David Johnson; Seth T Scanlon; Andrew N J McKenzie; Padraic G Fallon; Graham S Ogg Journal: J Exp Med Date: 2013-12-09 Impact factor: 14.307
Authors: B R Leaker; V A Malkov; R Mogg; M K Ruddy; G C Nicholson; A J Tan; C Tribouley; G Chen; I De Lepeleire; N A Calder; H Chung; P Lavender; L N Carayannopoulos; T T Hansel Journal: Mucosal Immunol Date: 2016-09-28 Impact factor: 7.313
Authors: Luan D Vu; David Siefker; Tamekia L Jones; Dahui You; Ryleigh Taylor; John DeVincenzo; Stephania A Cormier Journal: Am J Respir Crit Care Med Date: 2019-12-01 Impact factor: 21.405
Authors: Kangyun Wu; Xinyu Wang; Shamus P Keeler; Benjamin J Gerovac; Eugene V Agapov; Derek E Byers; Susan Gilfillan; Marco Colonna; Yong Zhang; Michael J Holtzman Journal: J Immunol Date: 2020-07-08 Impact factor: 5.422
Authors: Siti Muhamad Nur Husna; Hern-Tze Tina Tan; Norasnieda Md Shukri; Noor Suryani Mohd Ashari; Kah Keng Wong Journal: Front Immunol Date: 2021-05-21 Impact factor: 7.561